Achillion Pharmaceuticals Inc

CIK 1070336 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Achillion Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 16, 2021SC 13G/A0000354204-21-000634
Feb 14, 2020SC 13G/A0001493152-20-002369
Feb 14, 2020SC 13G0001140361-20-003382
Feb 12, 2020SC 13G/A0001104659-20-017780
Feb 12, 2020SC 13G/A0001258897-20-000748
Feb 10, 2020SC 13G/A0000834237-20-008677
Feb 7, 202015-12B0001193125-20-027298
Jan 31, 2020EFFECT9999999995-20-000203
Jan 31, 2020EFFECT9999999995-20-000204
Jan 31, 2020EFFECT9999999995-20-000202
Jan 31, 2020EFFECT9999999995-20-000201
Jan 30, 202030001104659-20-008790
Jan 30, 202040001104659-20-008815
Jan 29, 202040001562180-20-000678
Jan 29, 202040000904454-20-000088
Jan 29, 202040001562180-20-000674
Jan 29, 202040001562180-20-000669
Jan 29, 202040001562180-20-000670
Jan 29, 202040001562180-20-000675
Jan 29, 202040001562180-20-000677
Jan 29, 202040001562180-20-000679
Jan 29, 202040001562180-20-000668
Jan 29, 202040001562180-20-000673
Jan 29, 202040001562180-20-000672
Jan 29, 202040001562180-20-000671